arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Encompass Health Corp

EHC
$141.30 ▲ +0.20 (+0.14%) at close
Healthcare ·Services-Hospitals ·USServices-Hospitals
19 Visible periods
33 Metrics
Peer-ranked Benchmarks
Price Chart
76
Health
Good
Bullish
auto_awesome

Analytical Summary

Encompass Health Corp shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $14.2B
Dividend Yield 0.12%
Revenue Growth 10.5% ↘
Op. Margin None
ROIC None
FCF / Share None
Trailing P/E 25.1x
Price / Book 5.8x
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

19-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$5.94B
↑ +10.5% —
Net Income Profit after all expenses
$566.20M
↑ +24.2% —
Operating Margin Operating profit as % of sales
12.4%
↓ -11.0% —
FCF / Share Free cash flow per share
$1.42
↓ -26.4% —
Long-Term Debt Long-term obligations
$1.25B
↓ -17.0% —
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability ↓
64
Returns ↑
89

Dividend History

Dividend / share · sourced from SEC filings
$0.17 Latest / share
+13.3% YoY
-1.9% 12-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 19 years · 73 quarters